<DOC>
	<DOCNO>NCT00797771</DOCNO>
	<brief_summary>Approximately 250,000 people worldwide currently treat insulin pump . This number grow dramatically device become small user-friendly . Insulin pump allow tight metabolic control lifestyle flexibility minimize number hypoglycemic event . The NiliMedix ADI Insulin Pump ambulatory , battery operate , rate programmable micro- infusion pump , design continuous delivery insulin . A custom reservoir driven pressure insulin within deliver preset basal profile patient program bolus insulin custom infusion set , subcutaneous tissue . This type device require extensive user interaction education order ensure safety . This study design test independent home-use NiliMedix ADI Insulin Pump , evaluate user 's satisfaction .</brief_summary>
	<brief_title>User Satisfaction Using ADI Insulin Pump</brief_title>
	<detailed_description />
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Male/female age 18 year . Subject diagnose Type 1 Diabetes . Pump Users least 6 month HbA1c : le 8.5 % Capable reading pump screen English . Subject understand study procedure . Subject willing sign inform consent form comply study requirement . Major physical , motor , mental , behavioral , psychiatric limitation . Subject experience severe hypoglycemic episode lead hospitalization last 6 month . Subject experience episode Ketoacidosis last 6 month , use insulin pump . Concurrent additional major illness . Subject object study protocol . Physician objection Concurrent participation study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2009</verification_date>
	<keyword>Insulin delivery</keyword>
</DOC>